Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B. Gilbert, Lynn Morris, Tandile Hermanus et al.|Nature Medicine|2022Cited by 132
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisitionKelly E. Seaton, Georgia D. Tomaras, Yunda Huang et al.|EBioMedicine|2023Cited by 33
Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19Daniel J. Schuster, Shelly Karuna, Caroline Brackett et al.|JCI Insight|2022Cited by 21
Pharmacokinetic Serum Concentrations of VRC01 Correlate with Prevention of HIV-1 AcquisitionKelly E. Seaton, Georgia D. Tomaras, Yunda Huang et al.|SSRN Electronic Journal|2022Cited by 2
Distinct immune responses in people living with HIV following SARS-CoV-2 recoveryDieter Mielke, Guido Ferrari, Shuying Sue Li et al.|Communications Medicine|2025Cited by 1